Publication
Preoperative Risk Score (PreopScore) to Predict Overall Survival After Resection for Hepatocellular Carcinoma.
dc.contributor.author | Endo, Yutaka | |
dc.contributor.author | Lima, Henrique A | |
dc.contributor.author | Alaimo, Laura | |
dc.contributor.author | Moazzam, Zorays | |
dc.contributor.author | Brown, Zachary | |
dc.contributor.author | Shaikh, Chanza F | |
dc.contributor.author | Ratti, Francesca | |
dc.contributor.author | Pinto Marques, Hugo | |
dc.contributor.author | Soubrane, Olivier | |
dc.contributor.author | Lam, Vincent | |
dc.contributor.author | Poultsides, George A | |
dc.contributor.author | Popescu, Irinel | |
dc.contributor.author | Alexandrescu, Sorin | |
dc.contributor.author | Martel, Guillaume | |
dc.contributor.author | Workneh, Aklile | |
dc.contributor.author | Guglielmi, Alfredo | |
dc.contributor.author | Hugh, Tom | |
dc.contributor.author | Aldrighetti, Luca | |
dc.contributor.author | Shen, Feng | |
dc.contributor.author | Endo, Itaru | |
dc.contributor.author | Pawlik, Timothy M | |
dc.contributor.editor | Elsevier | |
dc.date.accessioned | 2025-04-15T15:06:44Z | |
dc.date.available | 2025-04-15T15:06:44Z | |
dc.date.issued | 2023-03 | |
dc.description.abstract | Background: This study aimed to develop a holistic risk score incorporating preoperative tumor, liver, nutritional, and inflammatory markers to predict overall survival (OS) after hepatectomy for hepatocellular carcinoma (HCC). Methods: Patients who underwent curative-intent surgery for HCC between 2000 and 2020 were identified using an international multi-institutional database. Preoperative predictors associated with OS were selected and a prognostic risk score model (PreopScore) was developed and validated using cross-validation. Results: A total of 1676 patients were included. On multivariable analysis, preoperative parameters associated with OS included α-feto protein (hazard ratio [HR]1.17, 95%CI 1.03-1.34), neutrophil-to-lymphocyte ratio (HR2.62, 95%CI 1.30-5.30), albumin (HR0.49, 95%CI 0.34-0.70), gamma-glutamyl transpeptidase (HR1.00, 95%CI 1.00-1.00), as well as vascular involvement (HR3.52, 95%CI 2.10-5.89) and tumor burden score (medium, HR3.49, 95%CI 1.62-7.58; high, HR3.21, 95%CI 1.40-7.35) on preoperative imaging. A weighted PreopScore was devised and made available online (https://yutaka-endo.shinyapps.io/PrepoScore_Shiny/). Patients with a PreopScore 0-2, 2-3.5, and >3.5 had incrementally worse 5-year OS of 85.8%, 70.7%, and 52.4%, respectively (p < 0.001). The c-index of the test and validation cohort were 0.75 and 0.71, respectively. The PreopScore outperformed individual parameters and previous HCC staging systems. Discussion: The PreopScore can be used as a better guide to preoperatively identify patients and individualize pre-/post-operative strategies. | eng |
dc.identifier.citation | HPB (Oxford) . 2023 Mar;25(3):353-362. | |
dc.identifier.doi | 10.1016/j.hpb.2022.12.009 | |
dc.identifier.pmid | 36670007 | |
dc.identifier.uri | http://hdl.handle.net/10400.17/5069 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Elsevier | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | HCC CIR | |
dc.subject | Humans | |
dc.subject | Prognosis | |
dc.subject | Carcinoma | |
dc.subject | Hepatocellular* / surgery | |
dc.subject | Hepatectomy | |
dc.subject | Liver Neoplasms* / surgery | |
dc.subject | Retrospective Studies | |
dc.title | Preoperative Risk Score (PreopScore) to Predict Overall Survival After Resection for Hepatocellular Carcinoma. | eng |
dc.type | text | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 362 | |
oaire.citation.issue | 3 | |
oaire.citation.startPage | 353 | |
oaire.citation.title | HPB | |
oaire.citation.volume | 25 | |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |